Login to Your Account

After Long Wait, SkyePharma Finds Flutiform's U.S. Partner

By Nuala Moran

Wednesday, May 10, 2006
LONDON - SkyePharma plc finally signed a U.S. partner for its combination asthma treatment Flutiform, after a year of prevarication that forced the company into an unwelcome rights issue and led to the resignation of both the founding chairman and the CEO. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription